XTSX
RKV
Market cap8mUSD
, Last price
CAD
Name
Rakovina Therapeutics Inc
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
Key people
Mads Daugaard
President, Chief Scientific Officer
Alfredo DeLucrezia
Independent Non-Executive Vice Chairman of the Board · since 2023
John Langlands
Chief Operating Officer
David Kideckel
Director · since 2025
Yevgeniy Meshcherekov
Director · since 2025
Dennis Brown
Independent Director · since 2023
Independent Director · since 2026
IPO date
Feb 07, 2020
Employees
Domiciled in
CA
Incorporated in
CA
Valuation
No data to show